Jun 12, 2026
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.01 to $0.45.
The split itself did not change the total investment value.
Alterity Therapeutics Ltd. (ASX:ATH) operates in the Pharmaceuticals: major industry.
Alterity Therapeutics Ltd. company overviewAlterity Therapeutics Ltd.'s most recent stock split was on June 12, 2026. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
Alterity Therapeutics Ltd. (ASX:ATH) has split its stock 2 times: a 1-for-50 reverse split on June 3, 2026 and a 1-for-50 reverse split on June 12, 2026.
Alterity Therapeutics Ltd. has split its stock 2 times. This history records 2 reverse splits between June 3, 2026 and June 12, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Alterity Therapeutics Ltd.'s 1-for-50 reverse split on June 12, 2026, every 50 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Alterity Therapeutics Ltd. has not announced a new split in our records. Its most recent split was on June 12, 2026, less than a year ago. Companies announce splits in advance, and any new ASX:ATH split will appear on this page.
Already premium?